Physician's Weekly - 08 Jun 2022
TUESDAY, June 7, 2022 (HealthDay News) -- A U.S. Food and Drug Administration vaccine advisory panel will weigh whether to recommend the emergency use of ...
Novavax Investor Relations - 11 Jun 2025
Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial ...